Correlation Between Pulmatrix and Regulus Therapeutics
Can any of the company-specific risk be diversified away by investing in both Pulmatrix and Regulus Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pulmatrix and Regulus Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pulmatrix and Regulus Therapeutics, you can compare the effects of market volatilities on Pulmatrix and Regulus Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pulmatrix with a short position of Regulus Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pulmatrix and Regulus Therapeutics.
Diversification Opportunities for Pulmatrix and Regulus Therapeutics
-0.27 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Pulmatrix and Regulus is -0.27. Overlapping area represents the amount of risk that can be diversified away by holding Pulmatrix and Regulus Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Regulus Therapeutics and Pulmatrix is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pulmatrix are associated (or correlated) with Regulus Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Regulus Therapeutics has no effect on the direction of Pulmatrix i.e., Pulmatrix and Regulus Therapeutics go up and down completely randomly.
Pair Corralation between Pulmatrix and Regulus Therapeutics
Given the investment horizon of 90 days Pulmatrix is expected to generate 1.97 times more return on investment than Regulus Therapeutics. However, Pulmatrix is 1.97 times more volatile than Regulus Therapeutics. It trades about 0.14 of its potential returns per unit of risk. Regulus Therapeutics is currently generating about -0.04 per unit of risk. If you would invest 197.00 in Pulmatrix on September 3, 2024 and sell it today you would earn a total of 437.00 from holding Pulmatrix or generate 221.83% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Pulmatrix vs. Regulus Therapeutics
Performance |
| Timeline |
| Pulmatrix |
| Regulus Therapeutics |
Pulmatrix and Regulus Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Pulmatrix and Regulus Therapeutics
The main advantage of trading using opposite Pulmatrix and Regulus Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pulmatrix position performs unexpectedly, Regulus Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Regulus Therapeutics will offset losses from the drop in Regulus Therapeutics' long position.| Pulmatrix vs. DiaMedica Therapeutics | Pulmatrix vs. Lyra Therapeutics | Pulmatrix vs. Centessa Pharmaceuticals PLC |
| Regulus Therapeutics vs. Tenax Therapeutics | Regulus Therapeutics vs. Verastem | Regulus Therapeutics vs. Pulmatrix | Regulus Therapeutics vs. Cellectar Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Other Complementary Tools
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |